Search results for "Atrial fibrillation"
‘Wearables' warrant wary expectations
Medical-grade wearable technology will be a $24 billion market by 2022, and the market is predicted to shift from recreational use toward disease diagnosis and management.
https://immattersacp.org/archives/2018/07/wearables-warrant-wary-expectations.htm
1 Jul 2018
Warfarin associated with lower stroke, systemic thromboembolism risk in patients with both afib and CKD
The addition of chronic kidney disease (CKD) to atrial fibrillation is associated with an increased risk of stroke or systemic thromboembolism and bleeding. Warfarin treatment was associated with decreasing this risk, a new study found.
https://immattersacp.org/weekly/archives/2012/08/21/6.htm
21 Aug 2012
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
Comparison with warfarin comes out well for dabigatran
Dabigatran (Pradaxa) was associated with a lower risk of clot-related strokes, intracranial hemorrhage, and death than warfarin, according to a recent study conducted by the FDA.
https://immattersacp.org/weekly/archives/2014/05/20/8.htm
20 May 2014
Higher CHADS2 scores can indicate higher risk in patients on anticoagulants
Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011
Rivaroxaban has similar safety, efficacy versus warfarin in older and younger nonvalvular afib patients
Rivaroxaban appears to have similar safety and efficacy compared with warfarin in both older and younger patients with nonvalvular atrial fibrillation, although stroke and major bleeding rates were higher in the former group, a new study found.
https://immattersacp.org/weekly/archives/2014/06/10/6.htm
10 Jun 2014
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013
New oral anticoagulants may slightly decrease all-cause mortality when compared to warfarin, meta-analysis suggests
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found.
https://immattersacp.org/weekly/archives/2013/12/10/6.htm
10 Dec 2013
Updated guidelines released on antithrombotic therapy, thrombosis prevention
The American College of Chest Physicians released updated guidelines last week on antithrombotic therapy and prevention of thrombosis.
https://immattersacp.org/weekly/archives/2012/02/14/2.htm
14 Feb 2012
More bleeds and clots in afib patients who took NSAIDs
Patients with atrial fibrillation who were prescribed NSAIDs had more serious bleeding and thromboembolic events than those not on NSAIDs, a new Danish study found.
https://immattersacp.org/weekly/archives/2014/11/18/1.htm
18 Nov 2014